Zobrazeno 1 - 10
of 1 118
pro vyhledávání: '"Elizabeth Garrett"'
Autor:
Abdul-Rahman Jazieh, Adda Bounedjar, Hikmat Abdel-Razeq, Elif Berna Koksoy, Jawaher Ansari, Arafat H. Tfayli, Emad M. Tashkandi, Wasil A. Jastaniah, Mohamed Osama Alorabi, Amira D. Darwish, Ahmed Magdy Rabea, Ashwaq Al Olayan, Fahad Ibnshamsah, Hassan Errihani, Mohammad Omar AlKaiyat, Fazal Hussain, Khaled Alkattan, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Hani Tamim
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 7, Iss 2, Pp 82-88 (2024)
Introduction: Despite extensive studies of the impact of COVID-19 on patients with cancer, there is a dearth of information from the Middle East and North Africa (MENA) region. Our study aimed to report pertinent MENA COVID-19 and Cancer Registry (MC
Externí odkaz:
https://doaj.org/article/fc722e7c16a249d5a2d715d86049a499
Autor:
Skylarr Beerman, Asaad Chaudhry, Kelsi Batioja, Philo Waters, Elizabeth Garrett, Andriana Peña, Matt Vassar
Publikováno v:
Health Sciences Review, Vol 9, Iss , Pp 100139- (2023)
Lung transplantation has proven to be an effective treatment for end-stage lung diseases. Recognizing and acknowledging the effects of health inequities pertaining to lung transplants is important for under-resourced populations. This scoping review
Externí odkaz:
https://doaj.org/article/3957b3b763e84416a0a490fe0e2b6960
Autor:
Kathryn F. Mileham, Caroline Schenkel, Suanna S. Bruinooge, Janet Freeman‐Daily, Upal Basu Roy, Amy Moore, Robert A. Smith, Elizabeth Garrett‐Mayer, Lauren Rosenthal, Edward B. Garon, Bruce E. Johnson, Raymond U. Osarogiagbon, Shadia Jalal, Shamsuddin Virani, Mary Weber Redman, Gerard A. Silvestri
Publikováno v:
Cancer Medicine, Vol 11, Iss 2, Pp 530-538 (2022)
Abstract Background An ASCO taskforce comprised of representatives of oncology clinicians, the American Cancer Society National Lung Cancer Roundtable (NLCRT), LUNGevity, the GO2 Foundation for Lung Cancer, and the ROS1ders sought to: characterize U.
Externí odkaz:
https://doaj.org/article/77e04cdb969842218b3ff0a67980c00e
Autor:
W. Katherine Tan, Brian D. Segal, Melissa D. Curtis, Shrujal S. Baxi, William B. Capra, Elizabeth Garrett-Mayer, Brian P. Hobbs, David S. Hong, Rebecca A. Hubbard, Jiawen Zhu, Somnath Sarkar, Meghna Samant
Publikováno v:
Contemporary Clinical Trials Communications, Vol 30, Iss , Pp 101000- (2022)
Background: Hybrid controlled trials with real-world data (RWD), where the control arm is composed of both trial and real-world patients, could facilitate research when the feasibility of randomized controlled trials (RCTs) is challenging and single-
Externí odkaz:
https://doaj.org/article/55c43bce2efa4cd8a8dc5818e59052f3
Autor:
Anvesh Kompelli, Kathleen B. Cartmell, Katherine R. Sterba, Anthony J. Alberg, Christopher C. Xiao, Amit J. Sood, Elizabeth Garrett-Mayer, Shai J. White-Gilbertson, Steven A. Rosenzweig, Terry A. Day
Publikováno v:
World Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 6, Iss 1, Pp 41-48 (2020)
Objective: Racial disparities have been well characterized and African American (AA) patients have 30% lower 5-year survival rates than European Americans (EAs) for head and neck squamous carcinoma (HNSCC). This poorer survival can be attributed to a
Externí odkaz:
https://doaj.org/article/296d16c693ba44ac9e46ee35e1ad46e1
Autor:
Hannah M. Knochelmann, Joshua D. Horton, Sixue Liu, Kent Armeson, John M. Kaczmar, Megan M. Wyatt, Mary S. Richardson, Shirley H. Lomeli, Ying Xiong, Evan M. Graboyes, Eric J. Lentsch, Joshua D. Hornig, Judith Skoner, Seth Stalcup, Maria V. Spampinato, Elizabeth Garrett-Mayer, Elizabeth C. O’Quinn, Cynthia D. Timmers, Martin J. Romeo, John M. Wrangle, M. Rita I. Young, Mark P. Rubinstein, Terry A. Day, Roger S. Lo, Chrystal M. Paulos, David M. Neskey
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 10, Pp 100426- (2021)
Summary: Oral cavity squamous cell carcinoma (OCSCC) is a prevalent surgically treated subset of head and neck cancer with frequent recurrence and poor survival. Immunotherapy has demonstrated efficacy in recurrent/metastatic head and neck cancer. Ho
Externí odkaz:
https://doaj.org/article/106d0eef51b345229c78936aef78ee40
Autor:
Collin Homer-Bouthiette, Yang Zhao, Lauren B. Shunkwiler, Benjamine Van Peel, Elizabeth Garrett-Mayer, Rachael C. Baird, Anna I. Rissman, Stephen T. Guest, Stephen P. Ethier, Manorama C. John, Patricia A. Powers, Jill D. Haag, Michael N. Gould, Bart M. G. Smits
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-16 (2018)
Abstract Background The gene desert on human chromosomal band 8q24 harbors multiple genetic variants associated with common cancers, including breast cancer. The locus, including the gene desert and its flanking genes, MYC, PVT1 and FAM84B, is also f
Externí odkaz:
https://doaj.org/article/b21bf55990924a71bc092663c943b4b4
Autor:
Patricia Kearney, John M Watkins, Keisuke Shirai, Amy E Wahlquist, John A Fortney, Elizabeth Garrett-Mayer, M. Boyd Gillepsie, Anand K Sharma
Publikováno v:
McGill Journal of Medicine, Vol 13, Iss 2 (2020)
Background: Primary management of advanced head/neck cancers involves concurrent chemoradiotherapy . Subsequently, regional and local failures are managed with resection but there have been few reports that describe the morbidity and disease control
Externí odkaz:
https://doaj.org/article/d5d9b88841d6409aa2db0ac6ec9cafc6
Autor:
Kendra C. Foley, Timothy T. Spear, David C. Murray, Kaoru Nagato, Elizabeth Garrett-Mayer, Michael I. Nishimura
Publikováno v:
Molecular Therapy: Oncolytics, Vol 5, Iss C, Pp 105-115 (2017)
T cell receptor (TCR)-gene-modified T cells for adoptive cell transfer can mediate objective clinical responses in melanoma and other malignancies. When introducing a second TCR, mispairing between the endogenous and introduced α and β TCR chains l
Externí odkaz:
https://doaj.org/article/3189595fbbd7476cb5193f7c6d87a5a8
Autor:
Shikhar Mehrotra, Carolyn D. Britten, Steve Chin, Elizabeth Garrett-Mayer, Colleen A. Cloud, Mingli Li, Gina Scurti, Mohamed L. Salem, Michelle H. Nelson, Melanie B. Thomas, Chrystal M. Paulos, Andres M. Salazar, Michael I. Nishimura, Mark P. Rubinstein, Zihai Li, David J. Cole
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-13 (2017)
Abstract Background Dendritic cells (DCs) enhance the quality of anti-tumor immune response in patients with cancer. Thus, we posit that DC-based immunotherapy, in conjunction with toll-like receptor (TLR)-3 agonist poly-ICLC, is a promising approach
Externí odkaz:
https://doaj.org/article/24af04bf4a4248ecafa4d737c8c57263